OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 21, 2021
ANGUS’ planned expansion will double its tromethamine buffer production capacity.
August 19, 2021
A new method developed by the NIH bypasses genetic RNA extraction, simplifying the testing process.
August 12, 2021
A collaboration between Aldevron and Ginkgo Bioworks has resulted in a manufacturing enhancement that can improve production of an enzyme used for mRNA therapeutics.
June 08, 2021
AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.
October 15, 2020
Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio.
July 21, 2020
GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.
July 02, 2020
RNA is easier to manipulate than DNA but challenging to deliver to the right cells.
July 01, 2019
Research from the Institute for Research in Biomedicine offers insight into the source of asymmetry between nucleic acid hybrids.
September 07, 2018
Bio-Rad introduces CHT Ceramic Hydroxyapatite XT media and Nuvia HP-Q resin resin for process protein purification.
August 13, 2018
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.